EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Reduced in utero substrate supply decreases mitochondrial abundance and alters the expression of metabolic signalling molecules in the fetal sheep heart

Catherine G Dimasi, Jack R T Darby, Steven K S Cho, Brahmdeep S Saini, Stacey L Holman, Ashley S Meakin, Michael D Wiese, Christopher K Macgowan, Mike Seed, Janna L Morrison

The Journal of Physiology · 2024

DOI: 10.1113/jp285572 ↗

At a glance

Journal article in The Journal of Physiology, 2024. Written by Catherine G Dimasi and 9 co-authors. Institution: Early Origins of Adult Health Research Group, Health and Biomedical Innovation, UniSA: Clinical and Health Sciences, University of South Australia, A…. Major MEDLINE topics: Fetal Growth Retardation, Fetal Heart. Cited 22 times so far (Crossref); 111 references. The full text is freely available (open access, CC BY 4.0). Funded by: CIHR, NHMRC Career Development Fellowship, ARC Future Fellowship.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Babies born with fetal growth restriction (FGR) are at higher risk of developing cardiometabolic diseases across the life course. The reduction in substrate supply to the developing fetus that causes FGR not only alters cardiac growth and structure but may have deleterious effects on metabolism and function. Using a sheep model of placental restriction to induce FGR, we investigated key cardiac metabolic and functional markers that may be altered in FGR. We also employed phase‐contrast magnetic resonance imaging MRI to assess left ventricular cardiac output (LVCO) as a measure of cardiac function. We hypothesized that signalling molecules involved in cardiac fatty acid utilisation and contractility would be impaired by FGR and that this would have a negative impact on LVCO in the late gestation fetus. Key glucose (GLUT4 protein) and fatty acid ( FATP , CD36 gene expression) substrate transporters were significantly reduced in the hearts of FGR fetuses. We also found reduced mitochondrial numbers as well as abundance of electron transport chain complexes (complexes II and IV). These data suggest that FGR diminishes metabolic and mitochondrial capacity in the fetal heart; however, alterations were not correlated with fetal LVCO. Overall, these data show that FGR alters fetal cardiac metabolism in late gestation. If sustained ex utero , this altered metabolic profile may contribute to poor cardiac outcomes in FGR‐born individuals after birth. image Key points Around the time of birth, substrate utilisation in the fetal heart switches from carbohydrates to fatty acids. However, the effect of fetal growth restriction (FGR) on this switch, and thus the ability of the fetal heart to effectively metabolise fatty acids, is not fully understood. Using a sheep model of early onset FGR, we observed significant downregulation in mRNA expression of fatty acid receptors CD36 and FABP in the fetal heart. FGR fetuses also had significantly lower cardiac mitochondrial abundance than controls. There was a reduction in abundance of complexes II and IV within the electron transport chain of the FGR fetal heart, suggesting altered ATP production. This indicates reduced fatty acid metabolism and mitochondrial function in the heart of the FGR fetus, which may have detrimental long‐term implications and contribute to increased risk of cardiovascular disease later in life.

Subjects

MeSH terms (MEDLINE)

Fetal Growth RetardationFetal HeartAnimalsFemaleSheepPregnancyMitochondria, HeartCD36 AntigensFatty AcidsMyocardiumSignal TransductionGlucose Transporter Type 4

Author keywords

FGRIUGRcardiac outputfetushypoxiamagnetic resonance imagingmetabolismmitochondria

Substances

CD36 AntigensFatty AcidsGlucose Transporter Type 4

Authors and institutions

  • Early Origins of Adult Health Research Group, Health and Biomedical Innovation, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.
  • Department of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Research Institute, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Department of Medical Biophysics, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Division of Cardiology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Funding

  • CIHR
  • NHMRC Career Development Fellowship
  • ARC Future Fellowship
  • SickKids Research Institute
  • Canadian Institutes of Health Research

Cite

APA

Dimasi, C. G., Darby, J. R. T., Cho, S. K. S., Saini, B. S., Holman, S. L., Meakin, A. S., Wiese, M. D., Macgowan, C. K., Seed, M., & Morrison, J. L. (2024). Reduced in utero substrate supply decreases mitochondrial abundance and alters the expression of metabolic signalling molecules in the fetal sheep heart. The Journal of Physiology. https://doi.org/10.1113/jp285572

Vancouver

Dimasi CG, Darby JRT, Cho SKS, Saini BS, Holman SL, Meakin AS, et al. Reduced in utero substrate supply decreases mitochondrial abundance and alters the expression of metabolic signalling molecules in the fetal sheep heart. The Journal of Physiology. 2024. doi:10.1113/jp285572

BibTeX
@article{Dimasi2024,
  author = {Dimasi, Catherine G and Darby, Jack R T and Cho, Steven K S and Saini, Brahmdeep S and Holman, Stacey L and Meakin, Ashley S and Wiese, Michael D and Macgowan, Christopher K and Seed, Mike and Morrison, Janna L},
  title = {Reduced in utero substrate supply decreases mitochondrial abundance and alters the expression of metabolic signalling molecules in the fetal sheep heart},
  journal = {The Journal of Physiology},
  year = {2024},
  doi = {10.1113/jp285572}
}
Start for free →